These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2584499)

  • 1. Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography.
    Kubota K; Matsuzawa T; Amemiya A; Kondo M; Fujiwara T; Watanuki S; Ito M; Ido T
    J Comput Assist Tomogr; 1989; 13(6):1097-8. PubMed ID: 2584499
    [No Abstract]   [Full Text] [Related]  

  • 2. PET scan detects recurrent breast cancer.
    Health News; 2002 May; 8(5):9. PubMed ID: 12132415
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular imaging in breast cancer.
    Schuster DM; Halkar RK
    Radiol Clin North Am; 2004 Sep; 42(5):885-908, vi-vii. PubMed ID: 15337423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.
    Wahl RL; Cody R; Hutchins G; Mudgett E
    N Engl J Med; 1991 Jan; 324(3):200. PubMed ID: 1984203
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography (PET) scanning in breast cancer.
    Powe JE
    Br J Radiol; 1997 Jul; 70(835):668-70. PubMed ID: 9245877
    [No Abstract]   [Full Text] [Related]  

  • 6. False-positive positron emission tomographic scan for recurrent breast cancer resulting from a bee sting.
    Johnson DS; Wong JT; Coel MN
    Clin Nucl Med; 1999 Sep; 24(9):702-3. PubMed ID: 10478754
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of breast and gynecologic cancers by positron emission tomography.
    Dehdashti F; Siegel BA
    Semin Roentgenol; 2002 Apr; 37(2):151-68. PubMed ID: 12134368
    [No Abstract]   [Full Text] [Related]  

  • 8. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
    Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
    Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of positron emission tomography in the diagnosis of recurrent rectal cancer].
    Lehner B; Schlag P; Strauss L; Dimitrakopoulou A; Herfarth C
    Zentralbl Chir; 1990; 115(13):813-7. PubMed ID: 2238957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient.
    Franc BL; Hawkins RA
    Semin Roentgenol; 2007 Oct; 42(4):265-79. PubMed ID: 17919529
    [No Abstract]   [Full Text] [Related]  

  • 12. Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.
    Hama Y
    Int J Clin Oncol; 2006 Jun; 11(3):250-1. PubMed ID: 16850134
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic Challenges of Postsurgical Breast Cancer Recurrence.
    Castro GJ
    Radiol Technol; 2017 Sep; 89(1):92-94. PubMed ID: 28904164
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast recurrence of primary rectal lymphoma: documentation by (18)F-FDG-PET and histopathology.
    Basu S; Ramani SK; Ramadwar M
    Hell J Nucl Med; 2012; 15(2):153-4. PubMed ID: 22741152
    [No Abstract]   [Full Text] [Related]  

  • 15. False-positive positron emission tomographic scan and computed tomography for recurrent vaginal cancer: pitfalls of modern imaging techniques.
    Tjalma WA; Carp L; De Beeck BO
    Gynecol Oncol; 2004 Feb; 92(2):726-8. PubMed ID: 14766276
    [No Abstract]   [Full Text] [Related]  

  • 16. PET-FDG of pleomorphic xanthoastrocytoma.
    Bicik I; Raman R; Knightly JJ; Di Chiro G; Fulham MJ
    J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
    Hunter GJ; Choi NC; McLoud TC; Fischman AJ
    J Nucl Med; 1993 Sep; 34(9):1571-3. PubMed ID: 8394885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring liver tumor therapy with [18F]FDG positron emission tomography.
    Nagata Y; Yamamoto K; Hiraoka M; Abe M; Takahashi M; Akuta K; Nishimura Y; Jo S; Masunaga S; Kubo S
    J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of positron emission tomography.
    Laking GR; Price PM
    AJR Am J Roentgenol; 2002 Apr; 178(4):1030. PubMed ID: 11906897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.